| 000 | 01432 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511193904.0 | ||
| 264 | 0 | _c19920716 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSandoval, C | |
| 245 | 0 | 0 |
_aTranslocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 1992 |
||
| 300 |
_a513-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 11 |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 9 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xdrug therapy |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHead, D R | |
| 700 | 1 | _aMirro, J | |
| 700 | 1 | _aBehm, F G | |
| 700 | 1 | _aAyers, G D | |
| 700 | 1 | _aRaimondi, S C | |
| 773 | 0 |
_tLeukemia _gvol. 6 _gno. 6 _gp. 513-9 |
|
| 999 |
_c1609271 _d1609271 |
||